DYNLRB1

gene product
DNCL2A, DNLC2A, ROBLD1
This gene is a member of the roadblock dynein light chain family. The encoded cytoplasmic protein is capable of binding intermediate chain proteins, interacts with transforming growth factor-beta, and has been implicated in the regulation of actin modulating proteins. Upregulation of this gene has been associated with hepatocellular carcinomas, suggesting that this gene may be involved in tumor progression. Alternative splicing results in multiple transcript variants. Pseudogenes of this gene have been defined on chromosomes 12 and 18. [provided by RefSeq, Aug 2013]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
69 antibodies from 19 providers.

Antibody properties

General

Applications

or Cancel
Antibody
Proteintech Group
1 antibody
Abbkine Scientific Co.Ltd.
1 antibody
Affinity Biosciences
1 antibody
NovoPro Bioscience Inc.
1 antibody
LifeSpan BioSciences, Inc.
18 antibodies
antibodies-online
21 antibodies
Aviva Systems Biology
2 antibodies
OriGene
2 antibodies
Biorbyt
6 antibodies
Santa Cruz Biotechnology
1 antibody
Invitrogen Antibodies
3 antibodies
St John's Laboratory
2 antibodies
BioLegend (formerly Covance Antibody Products)
1 antibody
Boster Biological Technology
1 antibody
Creative Biolabs
1 antibody
Abbexa
3 antibodies
Creative Diagnostics
1 antibody
MyBioSource
1 antibody
Acris Antibodies GmbH
2 antibodies